Development and assessment of sustained release stavudine loaded microparticles
Stavudine (D4T) has been used as first line treatment for HIV/AIDS and is part of highly active anti retroviral treatment (HAART). It is an affordable medicine and its use is beneficial in resource limited settings. However D4T exhibits dose dependent side effects that may lead to non-adherence in p...
Main Author: | Zindove, Chiedza Cathrine |
---|---|
Format: | Others |
Language: | English |
Published: |
Rhodes University
2014
|
Online Access: | http://hdl.handle.net/10962/54722 |
Similar Items
-
Development of stavudine sustained release tablets: In-vitro studies
by: Venkateswarlu Kambham, et al.
Published: (2016-12-01) -
Coaxial Electrospray of Curcumin-Loaded Microparticles for Sustained Drug Release.
by: Shuai Yuan, et al.
Published: (2015-01-01) -
Is stavudine worth saving?
by: Tom Boyles
Published: (2012-06-01) -
Sustained release microparticles for pulmonary administration
by: Cook, Robert Owen
Published: (2004) -
Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies.
by: Leilei Zhang, et al.
Published: (2015-01-01)